BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 12296995)

  • 1. TAK1-dependent activation of AP-1 and c-Jun N-terminal kinase by receptor activator of NF-kappaB.
    Lee SW; Han SI; Kim HH; Lee ZH
    J Biochem Mol Biol; 2002 Jul; 35(4):371-6. PubMed ID: 12296995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of c-Jun N-terminal kinase and activator protein 1 by receptor activator of nuclear factor kappaB.
    Lee ZH; Kwack K; Kim KK; Lee SH; Kim HH
    Mol Pharmacol; 2000 Dec; 58(6):1536-45. PubMed ID: 11093794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptor activator of NF-kappaB ligand (RANKL) activates TAK1 mitogen-activated protein kinase kinase kinase through a signaling complex containing RANK, TAB2, and TRAF6.
    Mizukami J; Takaesu G; Akatsuka H; Sakurai H; Ninomiya-Tsuji J; Matsumoto K; Sakurai N
    Mol Cell Biol; 2002 Feb; 22(4):992-1000. PubMed ID: 11809792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptor activator of NF-kappaB recruits multiple TRAF family adaptors and activates c-Jun N-terminal kinase.
    Kim HH; Lee DE; Shin JN; Lee YS; Jeon YM; Chung CH; Ni J; Kwon BS; Lee ZH
    FEBS Lett; 1999 Jan; 443(3):297-302. PubMed ID: 10025951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of NF-kappaB by RANK requires tumor necrosis factor receptor-associated factor (TRAF) 6 and NF-kappaB-inducing kinase. Identification of a novel TRAF6 interaction motif.
    Darnay BG; Ni J; Moore PA; Aggarwal BB
    J Biol Chem; 1999 Mar; 274(12):7724-31. PubMed ID: 10075662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysine 63-linked polyubiquitination of TAK1 at lysine 158 is required for tumor necrosis factor alpha- and interleukin-1beta-induced IKK/NF-kappaB and JNK/AP-1 activation.
    Fan Y; Yu Y; Shi Y; Sun W; Xie M; Ge N; Mao R; Chang A; Xu G; Schneider MD; Zhang H; Fu S; Qin J; Yang J
    J Biol Chem; 2010 Feb; 285(8):5347-60. PubMed ID: 20038579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the intracellular domain of receptor activator of NF-kappaB (RANK). Interaction with tumor necrosis factor receptor-associated factors and activation of NF-kappab and c-Jun N-terminal kinase.
    Darnay BG; Haridas V; Ni J; Moore PA; Aggarwal BB
    J Biol Chem; 1998 Aug; 273(32):20551-5. PubMed ID: 9685412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD27, a member of the tumor necrosis factor receptor superfamily, activates NF-kappaB and stress-activated protein kinase/c-Jun N-terminal kinase via TRAF2, TRAF5, and NF-kappaB-inducing kinase.
    Akiba H; Nakano H; Nishinaka S; Shindo M; Kobata T; Atsuta M; Morimoto C; Ware CF; Malinin NL; Wallach D; Yagita H; Okumura K
    J Biol Chem; 1998 May; 273(21):13353-8. PubMed ID: 9582383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo.
    Shim JH; Xiao C; Paschal AE; Bailey ST; Rao P; Hayden MS; Lee KY; Bussey C; Steckel M; Tanaka N; Yamada G; Akira S; Matsumoto K; Ghosh S
    Genes Dev; 2005 Nov; 19(22):2668-81. PubMed ID: 16260493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ASK1 inhibits interleukin-1-induced NF-kappa B activity through disruption of TRAF6-TAK1 interaction.
    Mochida Y; Takeda K; Saitoh M; Nishitoh H; Amagasa T; Ninomiya-Tsuji J; Matsumoto K; Ichijo H
    J Biol Chem; 2000 Oct; 275(42):32747-52. PubMed ID: 10921914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential requirements for tumor necrosis factor receptor-associated factor family proteins in CD40-mediated induction of NF-kappaB and Jun N-terminal kinase activation.
    Leo E; Welsh K; Matsuzawa S; Zapata JM; Kitada S; Mitchell RS; Ely KR; Reed JC
    J Biol Chem; 1999 Aug; 274(32):22414-22. PubMed ID: 10428814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TANK potentiates tumor necrosis factor receptor-associated factor-mediated c-Jun N-terminal kinase/stress-activated protein kinase activation through the germinal center kinase pathway.
    Chin AI; Shu J; Shan Shi C; Yao Z; Kehrl JH; Cheng G
    Mol Cell Biol; 1999 Oct; 19(10):6665-72. PubMed ID: 10490605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The involvement of multiple tumor necrosis factor receptor (TNFR)-associated factors in the signaling mechanisms of receptor activator of NF-kappaB, a member of the TNFR superfamily.
    Galibert L; Tometsko ME; Anderson DM; Cosman D; Dougall WC
    J Biol Chem; 1998 Dec; 273(51):34120-7. PubMed ID: 9852070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. JNK-binding protein 1 regulates NF-kappaB activation through TRAF2 and TAK1.
    Yamaguchi T; Miyashita C; Koyano S; Kanda H; Yoshioka K; Shiba T; Takamatsu N; Ito M
    Cell Biol Int; 2009 Mar; 33(3):364-8. PubMed ID: 19385034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The TRAF family of signal transducers mediates NF-kappaB activation by the TRANCE receptor.
    Wong BR; Josien R; Lee SY; Vologodskaia M; Steinman RM; Choi Y
    J Biol Chem; 1998 Oct; 273(43):28355-9. PubMed ID: 9774460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An intact zinc ring finger is required for tumor necrosis factor receptor-associated factor-mediated nuclear factor-kappaB activation but is dispensable for c-Jun N-terminal kinase signaling.
    Dadgostar H; Cheng G
    J Biol Chem; 1998 Sep; 273(38):24775-80. PubMed ID: 9733779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Xenopus death-domain-containing proteins FADD and RIP1 synergistically activate JNK and NF-kappaB.
    Ishizawa YH; Tamura K; Yamaguchi T; Matsumoto K; Komiyama M; Takamatsu N; Shiba T; Ito M
    Biol Cell; 2006 Aug; 98(8):465-78. PubMed ID: 16597320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor necrosis factor (TNF) receptor 1 signaling downstream of TNF receptor-associated factor 2. Nuclear factor kappaB (NFkappaB)-inducing kinase requirement for activation of activating protein 1 and NFkappaB but not of c-Jun N-terminal kinase/stress-activated protein kinase.
    Natoli G; Costanzo A; Moretti F; Fulco M; Balsano C; Levrero M
    J Biol Chem; 1997 Oct; 272(42):26079-82. PubMed ID: 9334169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ASK1 is essential for JNK/SAPK activation by TRAF2.
    Nishitoh H; Saitoh M; Mochida Y; Takeda K; Nakano H; Rothe M; Miyazono K; Ichijo H
    Mol Cell; 1998 Sep; 2(3):389-95. PubMed ID: 9774977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quercetin disrupts tyrosine-phosphorylated phosphatidylinositol 3-kinase and myeloid differentiation factor-88 association, and inhibits MAPK/AP-1 and IKK/NF-κB-induced inflammatory mediators production in RAW 264.7 cells.
    Endale M; Park SC; Kim S; Kim SH; Yang Y; Cho JY; Rhee MH
    Immunobiology; 2013 Dec; 218(12):1452-67. PubMed ID: 23735482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.